Chunghwa Chemical Synthesis & Biotech Co., Ltd. (1762.TW)

46.00 -0.30 (-0.65%) At close: 01:30PM CST

Chunghwa Chemical Synthesis & Biotech Co., Ltd.

No. 1 Tung-Hsing Street
Shu-Lin District
New Taipei City 23850
Taiwan
886 2 8684 3318
https://www.ccsb.com.tw

Sector(s): Healthcare
Industry: Biotechnology
Full-time employees: 

Key executives

Name	Title	Pay	Exercised	Year born
Mr. Chung-Hsin Huang	President & GM	N/A	N/A	N/A
Mr. Kuan-Chieh Wang	Manager of Finance & Treasury Dept., and Head of Accounting & Corporate Governance	N/A	N/A	N/A
Mr. Jun-Jie Liao	Manager of Human Resource Office	N/A	N/A	N/A
Mr. Chao-Sheng Hong	Chief Auditor	N/A	N/A	N/A

Amounts are as of , and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in TWD.

Description

Chunghwa Chemical Synthesis & Biotech Co., Ltd. engages in the research, development, manufacture, and sale of active pharmaceutical ingredients (APIs) in Taiwan and the United States. It offers API products, which include immunosuppressant, oncology, anti-virus, immunomodulating agents, and other products, as well as peptide drugs. The company also develops bulk pharmaceutical products, such as anti-anxiety agents, antidiabetics, laxatives, antifungals, antihistamines, antiseptics, antiulcerants, cardiovascular drugs, skeletal, muscle relaxants, hypolipaemics, antineoplastic, antihyperlipedemias, and immunosuppressant products, as well as provides research and development, and contract manufacturing services to new drug developers and generic drug companies. The company was formerly known as China Chemical Synthesis Industry Co., Ltd. Chunghwa Chemical Synthesis & Biotech Co., Ltd. was founded in 1964 and is headquartered in New Taipei City, Taiwan.

Corporate governance

Chunghwa Chemical Synthesis & Biotech Co., Ltd.’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.